Key products
Therapeutic Areas
Merck Serono - Transforming lives through medical science
Merck Serono is the largest division of Merck. It markets innovative prescription drugs of chemical and biotechnological origin. Merck Serono focuses on highly specialized therapeutic areas such as Neurodegenerative Diseases, Oncology, Fertility, Endocrinology and Rheumatology.More on Neurodegenerative Diseases on
Rebif® (multiple sclerosis)
Rebif® (interferon beta-1a) is a disease modifying drug (DMD) used to treat relapsing forms of multiple sclerosis (MS). It is similar to the interferon beta protein produced by the human body.More on Oncology on
Erbitux® (solid tumors)
The targeted oncology drug Erbitux® was launched in the EU for the fidionst-line treatment of recurrent or metastatic squamous cell carcinoma of the head and neck in 2009.UFT® (tegafur-uracil) oral 5-FU therapy
UFT (tegafur-uracil) is an oral chemotherapy agent that has obtained marketing authorization in about 50 countries. In the majority of these countries, UFT is registered in combination with folinic acid (LV) as a 1st line treatment for metastatic colorectal cancer. In many countries outside Europe UFT is approved to treat a variety of cancer types, including colorectal cancer, gastric cancer, breast cancer, and head and neck cancer. UFT is currently marketed in about 17 countries.More on Fertility on
GONAL-f®
GONAL-f® (follitropin alfa for injection) is prescribed to supplement or replace naturally occurring FSH, an essential hormone to treat infertility in both women and men.Pergoveris™
Pergoveris is indicated for the stimulation of follicular development in women with severe LH and FSH deficiency.Luveris®
Luveris® (lutropin alfa) is a luteinizing hormone (recombinant human LH) for the treatment of female infertility. It is indicated for use in combination with human follicle-stimulating hormone (hFSH), for the stimulation of follicles in the ovaries of women with severe LH and FSH deficiency.Ovitrelle®
Ovidrel®/Ovitrelle® (choriogonadotropin alfa) is indicated for the treatment of anovulation, or absence of ovulation, the most common cause of infertility in women.Crinone®
Crinone 8%® (progesterone gel) is a bioadhesive progesterone gel used in assisted reproductive technologies (ART) as luteal phase support for pregnancy.Cetrotide®
Cetrotide® (cetrorelix acetate for injection) is a gonadotropin releasing hormone (GnRH) antagonist used to prevent premature ovulation in controlled ovarian stimulation prior to assisted reproductive technologies (ART).More on Endocrinology on
Saizen® (growth hormone disorders)
Saizen® (somatropin for injection) is indicated for the treatment of growth hormone deficiency (GHD) in children and adults, Turner's syndrome, and chronic renal failure and children born short for gestational age (SGA).Kuvan® (metabolic disorder hyperphenylalaninemia)
Kuvan® has been available in the EU since 2009 for the treatment of hyperphenylalaninemia – a very rare and serious disease that can cause serious brain damage in infants and children if a strict diet is not adhered to at all times.More on CardioMetabolic Care on
Glucophage® franchise (type 2 diabetes)
Glucophage® (metformin hydrochloride) belongs to the biguanide class of molecules which decrease glucose production by the liver. It is approved as a first-line treatment for type 2 diabetes.Concor® franchise (cardiovascular diseases)
The Concor family of products is the backbone of Merck Serono’s cardiovascular franchise which is marketed along with a range of locally commercialized products.Euthyrox® (thyroid diseases)
Euthyrox® (levothyroxine sodium) is a synthetic thyroid hormone approved as the standard treatment for hypothyroidism. It is also indicated for treatment of euthyroid goiter and suppressive therapy of differentiated thyroid cancer.
